Cencora, Inc. $COR Holdings Lifted by Assenagon Asset Management S.A.

Key Points

• Assenagon Asset Management increased its Cencora stake by 129.6% in the second quarter, bringing its holdings to 586,914 shares valued at approximately $166.1 million. Institutional investors collectively own 97.52% of the company.
• Cencora reported a quarterly earnings beat, with adjusted EPS of $4.48 and revenue of $84.75 billion, while revenue rose 5.1% year over year. Management also raised fiscal 2026 adjusted EPS guidance to $17.75–$17.95.
• Analysts maintain a generally positive view, with a “Moderate Buy” consensus and a $371 average price target. Cencora also declared a $0.60 quarterly dividend and has authorization to repurchase up to $2 billion of stock.

Assenagon Asset Management S.A. grew its holdings in shares of Cencora, Inc. (NYSE:COR - Free Report) by 129.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 586,914 shares of the company's stock after buying an additional 331,340 shares during the period. Assenagon Asset Management S.A. owned 0.30% of Cencora worth $166,085,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Trust Asset Management LLC increased its position in Cencora by 9.3% in the 2nd quarter. Trust Asset Management LLC now owns 2,130 shares of the company's stock valued at $603,000 after acquiring an additional 181 shares during the period. Boltwood Capital Management boosted its position in Cencora by 9.2% during the 2nd quarter. Boltwood Capital Management now owns 1,962 shares of the company's stock worth $555,000 after acquiring an additional 166 shares during the period. CX Institutional boosted its position in Cencora by 28.7% during the 2nd quarter. CX Institutional now owns 27,069 shares of the company's stock worth $7,660,000 after acquiring an additional 6,030 shares during the period. SWP Investment Management LLC boosted its position in Cencora by 3.9% during the 2nd quarter. SWP Investment Management LLC now owns 10,059 shares of the company's stock worth $2,846,000 after acquiring an additional 380 shares during the period. Finally, Sapient Capital LLC bought a new position in shares of Cencora in the first quarter worth $262,000. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Cencora

Here are the key news stories impacting Cencora this week:

• Positive Sentiment: Quarterly earnings beat estimates. Cencora reported adjusted diluted EPS of $4.48, up from $4.00 a year ago and above the roughly $4.35-$4.37 analyst consensus. Revenue rose 5.1% year over year to approximately $84.8 billion, slightly exceeding expectations. Cencora Reports Fiscal 2026 Third Quarter Results
• Positive Sentiment: Management raised its fiscal 2026 adjusted EPS outlook to $17.75-$17.95 from $17.70-$17.90, while maintaining its approximately $3 billion free-cash-flow target. The guidance increase signals confidence in continued operating momentum. Cencora outlines fiscal 2026 EPS of $17.75-$17.95
• Positive Sentiment: Specialty pharmaceuticals remained the main growth driver. Strength in U.S. Healthcare Solutions, international operations and OneOncology helped support profit growth, while the company repurchased approximately $1 billion of stock during the quarter, potentially boosting per-share results. Cencora lifts annual profit view on strong demand for specialty medicines
• Positive Sentiment: Cencora declared a quarterly dividend of $0.60 per share, payable August 31 to shareholders of record August 14. The dividend is modest, with an annualized yield of about 0.7%, but reinforces the company’s capital-return program.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. William Blair assumed coverage on Cencora in a report on Tuesday, April 28th. They set a "market perform" rating on the stock. Morgan Stanley set a $342.00 price target on shares of Cencora in a research report on Friday, May 8th. Citigroup reaffirmed a "buy" rating on shares of Cencora in a research note on Thursday. Barclays decreased their price objective on shares of Cencora from $425.00 to $350.00 and set an "overweight" rating for the company in a report on Wednesday, June 10th. Finally, Robert W. Baird set a $370.00 price objective on shares of Cencora in a research note on Thursday. Eleven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $371.00.

Cencora Price Performance

Shares of Cencora stock opened at $325.02 on Friday. The company has a current ratio of 0.93, a quick ratio of 0.59 and a debt-to-equity ratio of 3.53. The company's 50-day moving average price is $292.86 and its two-hundred day moving average price is $314.37. Cencora, Inc. has a 52 week low of $244.82 and a 52 week high of $377.54. The stock has a market cap of $63.24 billion, a PE ratio of 24.15, a price-to-earnings-growth ratio of 1.76 and a beta of 0.57.

Cencora (NYSE:COR - Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $4.48 earnings per share for the quarter, beating the consensus estimate of $4.35 by $0.13. The company had revenue of $84.75 billion during the quarter, compared to analyst estimates of $84.31 billion. Cencora had a net margin of 0.79% and a return on equity of 125.45%. The business's revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter last year, the firm posted $4.00 EPS. As a group, sell-side analysts anticipate that Cencora, Inc. will post 17.8 EPS for the current fiscal year.

Cencora Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Friday, August 14th. Cencora's dividend payout ratio (DPR) is presently 17.83%.

Cencora announced that its Board of Directors has initiated a share repurchase program on Thursday, May 21st that authorizes the company to buyback $2.00 billion in outstanding shares. This buyback authorization authorizes the company to repurchase up to 3.9% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's leadership believes its shares are undervalued.

Insiders Place Their Bets

In other Cencora news, Director Lauren M. Tyler purchased 550 shares of the firm's stock in a transaction on Monday, June 22nd. The shares were purchased at an average price of $270.23 per share, for a total transaction of $148,626.50. Following the completion of the transaction, the director owned 4,359 shares in the company, valued at $1,177,932.57. This represents a 14.44% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.38% of the company's stock.

Cencora Profile

Cencora NYSE: COR is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company's core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.

Want to see what other hedge funds are holding COR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cencora, Inc. (NYSE:COR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source